Table 3.
All-cause Death | Cardiovascular Death | |
---|---|---|
Age | 1.04 (1.02–1.06, p<0.001) | 1.03 (1.00 – 1.06, p = 0.02) |
Gender | 1.50 (0.90 – 2.50, p=0.12) | 1.60 (0.79 – 3.26, p=0.19) |
Height | 1.00 (0.98 – 1.03, p=0.92) | 0.98 (0.95 – 1.02, p=0.29) |
Body Mass Index | 1.04 (1.00 – 1.09, p=0.03) | 1.07 (1.02 – 1.12, p=0.01) |
Any tobacco history | 0.78 (0.49 – 1.28, p=0.34) | 1.00 (0.52 – 1.92, p=1.0) |
Current tobacco | 0.66 (0.37 – 1.19, p=0.17) | 0.70 (0.32 – 1.54, p=0.38) |
Obesity (BMI > 30) | 1.35 (0.82 – 2.22, p=0.24) | 1.38 (0.71 – 2.70, p=0.34) |
Hyperlipidemia | 0.89 (0.53 – 1.48, p=0.65) | 0.95 (0.47 – 1.92, p=0.88) |
Hypertension | 0.42 (0.13 – 1.33, p=0.14) | 0.33 (0.08 – 1.37, p=0.13) |
Diabetes | 1.88 (1.17 – 3.03, p<0.01) | 1.87 (0.97 – 3.60, p=0.06) |
Congestive Heart Failure | 2.61 (1.54 – 4.44, p<0.001) | 5.37 (2.78 – 10.36, p<0.001) |
Cardiomyopathy | 2.20 (0.80 – 6.05, p=0.13) | 3.14 (0.96 –10.24, p=0.05) |
Chronic Obstructive Pulmonary Disease | 1.07 (0.56 – 2.04, p=0.84) | 1.12 (0.47 – 2.70, p=0.80) |
Prior Stroke/Transient Ischemic Attack | 1.56 (0.85 – 2.86, p=0.15) | 2.20 (1.04 – 4.68, p=0.04) |
Atrial Fibrillation | 5.39 (2.31 – 12.61, p<0.001) | 6.63 (2.31 – 19.00, p<0.001) |
Coronary Artery Disease | 2.01 (1.19 – 3.39, p<0.01) | 2.47 (1.16 – 5.26, p=0.02) |
End-Stage Renal Disease | 1.49 (0.78 – 2.84, p=0.23) | 0.98 (0.35 – 2.77, p=0.97) |
Prior Myocardial Infarction | 1.39 (0.74 – 2.60, p=0.30) | 1.79 (0.81 – 3.92, p=0.15) |
Prior Coronary Artery Bypass | 1.44 (0.85 – 2.44, p=0.18) | 1.84 (0.92 – 3.67, p=0.09) |
Known Peripheral Vascular Disease | 1.07 (0.56 – 2.04, p=0.85) | 1.47 (0.70 – 3.06, p=0.31) |
Baseline Hemoglobin | 0.81 (0.71 – 0.92, p<0.001) | 0.73 (0.61 – 0.88, p<0.001) |
Baseline Creatinine | 1.29 (1.04 – 1.59, p=0.02) | 1.23 (0.91 – 1.68, p=0.42) |
Shown are estimated Hazard Ratios (HR) and associated 95% Confidence intervals (CI).